These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8243271)

  • 1. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function.
    Ongphiphadhanakul B; Jenis LG; Braverman LE; Alex S; Stein GS; Lian JB; Baran DT
    Endocrinology; 1993 Dec; 133(6):2502-7. PubMed ID: 8243271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat model of thyroid hormone-induced bone loss: effect of antiresorptive agents on regional bone density and osteocalcin gene expression.
    Kung AW; Ng F
    Thyroid; 1994; 4(1):93-8. PubMed ID: 8054866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization.
    Suwanwalaikorn S; Van Auken M; Kang MI; Alex S; Braverman LE; Baran DT
    Am J Physiol; 1997 Feb; 272(2 Pt 1):E212-7. PubMed ID: 9124325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats.
    Suwanwalaikorn S; Ongphiphadhanakul B; Braverman LE; Baran DT
    Eur J Endocrinol; 1996 May; 134(5):655-9. PubMed ID: 8664988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin.
    Ongphiphadhanakul B; Alex S; Braverman LE; Baran DT
    J Bone Miner Res; 1992 Oct; 7(10):1227-31. PubMed ID: 1456090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo.
    Jenis LG; Ongphiphadhanakul B; Braverman LE; Stein GS; Lian JB; Lew R; Baran DT
    Calcif Tissue Int; 1994 Jun; 54(6):511-5. PubMed ID: 8082057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Olpadronate prevents cortical and trabecular bone loss induced by supraphysiological dosis of thyroxine in ovariectomized rats].
    Zeni SN; Gómez Acotto C; Di Gregorio S
    Medicina (B Aires); 1998; 58(5 Pt 1):453-7. PubMed ID: 9922475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
    Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
    J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.
    Milne M; Kang MI; Quail JM; Baran DT
    Endocrinology; 1998 May; 139(5):2527-34. PubMed ID: 9564868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats.
    Gouveia CH; Jorgetti V; Bianco AC
    J Bone Miner Res; 1997 Dec; 12(12):2098-107. PubMed ID: 9421243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.
    Bauer M; Fairbanks L; Berghöfer A; Hierholzer J; Bschor T; Baethge C; Rasgon N; Sasse J; Whybrow PC
    J Affect Disord; 2004 Dec; 83(2-3):183-90. PubMed ID: 15555712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
    Windahl SH; Hollberg K; Vidal O; Gustafsson JA; Ohlsson C; Andersson G
    J Bone Miner Res; 2001 Aug; 16(8):1388-98. PubMed ID: 11499861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.